SH PHARMACEU -H-

BE:S1R Germany Other
Market Cap
$11.65K
€11.35K EUR
Market Cap Rank
#44771 Global
#7366 in Germany
Share Price
€1.21
Change (1 day)
+0.00%
52-Week Range
€1.16 - €1.41
All Time High
€1.69
About

SH PHARMACEU -H- operates in Diversified Metals & Mining.

SH PHARMACEU -H- (S1R) - Total Liabilities

Latest total liabilities as of September 2024: €140.58 Billion EUR

Based on the latest financial reports, SH PHARMACEU -H- (S1R) has total liabilities worth €140.58 Billion EUR as of September 2024.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

SH PHARMACEU -H- - Total Liabilities Trend (2016–2023)

This chart illustrates how SH PHARMACEU -H-'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

SH PHARMACEU -H- Competitors by Total Liabilities

The table below lists competitors of SH PHARMACEU -H- ranked by their total liabilities.

Company Country Total Liabilities
Coil S.A./N.V
PA:ALCOI
France €13.52 Million
XLMedia PLC
PINK:XLMDF
USA $10.67 Million
CFECAPITAL S. De R.L. De C.V
MX:FCFE18
Mexico MX$112.01 Billion
BloomZ Inc. Ordinary Shares
NASDAQ:BLMZ
USA $215.22 Million
TransCanna Holdings Inc
PINK:TCNAF
USA $30.44 Million

Liability Composition Analysis (2016–2023)

This chart breaks down SH PHARMACEU -H-'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.34 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.98 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.63 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SH PHARMACEU -H-'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SH PHARMACEU -H- (2016–2023)

The table below shows the annual total liabilities of SH PHARMACEU -H- from 2016 to 2023.

Year Total Liabilities Change
2023-12-31 €131.65 Billion +9.58%
2022-12-31 €120.13 Billion +15.10%
2021-12-31 €104.37 Billion +10.51%
2020-12-31 €94.44 Billion +7.76%
2019-12-31 €87.64 Billion +8.94%
2018-12-31 €80.45 Billion +47.15%
2017-12-31 €54.67 Billion +19.08%
2016-12-31 €45.91 Billion --